Lonafarnib is indicated for use to scale back the risk of death due to Hutchinson-Gilford progeria syndrome and to the treatment of certain other processing-deficient progeroid laminopathies in people a single 12 months of age and older.[three][4] In some instances, health and fitness coverage companies could partially or entirely protect https://spencerlupkd.loginblogin.com/45331619/what-does-lonafarnib-zokinvy-mean